Clover Health Investments, Corp. (CLOV)
NASDAQ: CLOV · Real-Time Price · USD
3.920
+0.090 (2.35%)
At close: Jun 8, 2026, 4:00 PM EDT
4.010
+0.090 (2.30%)
Pre-market: Jun 9, 2026, 4:06 AM EDT
Clover Health Investments Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 173.27 | 78.3 | 194.54 | 116.41 | 103.79 | 299.97 |
Short-Term Investments | 30.28 | 41.96 | 27.01 | 119.82 | 230.97 | 315.29 |
Cash & Short-Term Investments | 203.54 | 120.26 | 221.56 | 236.23 | 334.76 | 615.26 |
Cash Growth | 27.14% | -45.72% | -6.21% | -29.43% | -45.59% | 536.18% |
Accounts Receivable | 73.47 | 94.87 | 51.54 | 64.16 | 70.61 | 48.04 |
Other Receivables | 129.22 | 63.88 | 41.25 | 22.08 | 96.94 | 61.38 |
Total Trade Receivables | 202.69 | 158.74 | 92.79 | 86.24 | 167.55 | 109.42 |
Other Current Assets | 41.79 | 28.86 | 28.78 | 105.5 | 122.69 | 27.87 |
Total Current Assets | 448.02 | 307.86 | 343.12 | 427.97 | 625 | 752.55 |
Net Property, Plant & Equipment | 6.9 | 6.39 | 5.31 | 5.08 | 9.78 | 7.65 |
Other Intangible Assets | 2.99 | 2.99 | 2.99 | 2.99 | - | - |
Goodwill | - | - | - | - | 20 | 4.23 |
Long-Term Investments | 214.68 | 199.66 | 216.06 | 121 | 138.11 | 175.94 |
Other Long-Term Assets | 25.13 | 24.12 | 13.26 | 13.63 | 15.74 | 10.43 |
Total Assets | 697.73 | 541.01 | 580.74 | 570.67 | 808.62 | 950.8 |
Accounts Payable | 39.17 | 36.21 | 34.56 | 37.18 | 32.45 | 28.13 |
Accrued Expenses | 31.23 | 16.04 | 19.09 | 20.95 | 23.96 | 15.15 |
Current Portion of Leases | - | - | - | - | 1.83 | 3.06 |
Other Current Liabilities | 266.18 | 156.57 | 159.86 | 202.98 | 373.27 | 326.29 |
Total Current Liabilities | 336.58 | 208.82 | 213.52 | 261.12 | 431.51 | 372.62 |
Long-Term Debt | - | - | - | - | - | 19.94 |
Long-Term Leases | - | - | - | - | 4.03 | 4.83 |
Other Long-Term Liabilities | 21.72 | 23.48 | 26.08 | 23.16 | 16.19 | 14.1 |
Total Long-Term Liabilities | 21.72 | 23.48 | 26.08 | 23.16 | 20.23 | 38.86 |
Total Liabilities | 358.3 | 232.31 | 239.6 | 284.28 | 451.73 | 411.49 |
Common Stock | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
Treasury Stock | -94.08 | -86.19 | -30.99 | -12.73 | -6.51 | -0.15 |
Additional Paid-in Capital | 2,695 | 2,683 | 2,576 | 2,461 | 2,319 | 2,154 |
Accumulated Other Comprehensive Income | -0.67 | 0.53 | -1.58 | -2.37 | -9.37 | -1.93 |
Retained Earnings | -2,261 | -2,288 | -2,203 | -2,160 | -1,946 | -1,617 |
Total Common Shareholders' Equity | 339.43 | 308.7 | 341.14 | 286.39 | 356.89 | 535.41 |
Minority Interest | - | - | - | - | - | 3.9 |
Shareholders' Equity | 339.43 | 308.7 | 341.14 | 286.39 | 356.89 | 539.32 |
Total Liabilities & Equity | 697.73 | 541.01 | 580.74 | 570.67 | 808.62 | 950.8 |
Total Debt | - | 0 | 0 | 0 | 5.86 | 27.83 |
Net Cash (Debt) | 203.54 | 120.26 | 221.56 | 236.23 | 328.9 | 587.43 |
Net Cash Growth | 69.26% | -45.72% | -6.21% | -28.18% | -44.01% | - |
Net Cash Per Share | 0.39 | 0.23 | 0.45 | 0.49 | 0.69 | 1.42 |
Book Value | 339.43 | 308.7 | 341.14 | 286.39 | 356.89 | 535.41 |
Book Value Per Share | 0.66 | 0.60 | 0.70 | 0.59 | 0.75 | 1.30 |
Tangible Book Value | 336.44 | 305.71 | 338.15 | 283.4 | 336.89 | 531.18 |
Tangible Book Value Per Share | 0.65 | 0.60 | 0.69 | 0.59 | 0.71 | 1.29 |